Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells $21,887.88 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 5,964 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $21,887.88. Following the completion of the transaction, the chief executive officer now directly owns 186,904 shares in the company, valued at approximately $685,937.68. This represents a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Amit Gupta also recently made the following trade(s):

• On Thursday, October 24th, Amit Gupta sold 22,607 shares of Cardlytics stock. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95.

Cardlytics Price Performance

Shares of CDLX opened at $3.35 on Thursday. The business has a 50-day simple moving average of $3.89 and a two-hundred day simple moving average of $4.77. The stock has a market cap of $170.25 million, a PE ratio of -0.55 and a beta of 1.53. Cardlytics, Inc. has a 12-month low of $2.89 and a 12-month high of $20.52. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Cardlytics (NASDAQ:CDLX) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The firm had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. During the same quarter last year, the firm earned ($0.26) earnings per share. The company’s revenue for the quarter was down 15.1% on a year-over-year basis. Analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Check Capital Management Inc. CA increased its stake in shares of Cardlytics by 10.4% in the third quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock valued at $162,000 after buying an additional 4,775 shares during the period. BNP Paribas Financial Markets boosted its holdings in Cardlytics by 32.1% in the third quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock valued at $63,000 after acquiring an additional 4,796 shares during the last quarter. Creative Planning increased its position in Cardlytics by 35.4% during the 3rd quarter. Creative Planning now owns 29,537 shares of the company’s stock valued at $95,000 after purchasing an additional 7,721 shares during the period. Atom Investors LP bought a new position in Cardlytics during the 3rd quarter worth approximately $33,000. Finally, Quest Partners LLC lifted its position in shares of Cardlytics by 160.4% in the 2nd quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock worth $147,000 after purchasing an additional 11,061 shares during the period. 68.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CDLX has been the topic of a number of research analyst reports. Evercore ISI initiated coverage on Cardlytics in a report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, November 7th. Finally, Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Cardlytics presently has a consensus rating of “Hold” and a consensus target price of $6.92.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.